Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
The body on fire.

U.S. news & world report

Hobson K.
PMID: 14584459
US News World Rep. 2003 Oct 20;135(13):42-4.

No abstract available.

Cite
Hobson K. The body on fire. US News World Rep. 2003;135(13):42-4
Hobson, K. (2003). The body on fire. U.S. news & world report, 135(13), 42-4.
Hobson, Katherine. "The body on fire." U.S. news & world report vol. 135,13 (2003): 42-4.
Hobson K. The body on fire. US News World Rep. 2003 Oct 20;135(13):42-4. PMID: 14584459.
Copy Download .nbib Format: NLM
Psychosocial factors at work and inflammatory markers: protocol for a systematic review and meta-analysis.

BMJ open

Eguchi H, Watanabe K, Kawakami N, Ando E, Arima H, Asai Y, Inoue A, Inoue R, Iwanaga M, Imamura K, Kobayashi Y, Nishida N, Otsuka Y, Sakuraya A, Tsuno K, Shimazu A, Tsutsumi A.
PMID: 30158233
BMJ Open. 2018 Aug 29;8(8):e022612. doi: 10.1136/bmjopen-2018-022612.

INTRODUCTION: Chronic inflammation may be a mediator for the development of cardiovascular disease (CVD), metabolic diseases and psychotic and neurodegenerative disorders. Meta-analytic associations between work-related psychosocial factors and inflammatory markers have shown that work-related psychosocial factors could affect the...

Cite
Eguchi H, Watanabe K, Kawakami N, et al. Psychosocial factors at work and inflammatory markers: protocol for a systematic review and meta-analysis. BMJ Open. 2018;8(8):e022612doi: 10.1136/bmjopen-2018-022612.
Eguchi, H., Watanabe, K., Kawakami, N., Ando, E., Arima, H., Asai, Y., Inoue, A., Inoue, R., Iwanaga, M., Imamura, K., Kobayashi, Y., Nishida, N., Otsuka, Y., Sakuraya, A., Tsuno, K., Shimazu, A., & Tsutsumi, A. (2018). Psychosocial factors at work and inflammatory markers: protocol for a systematic review and meta-analysis. BMJ open, 8(8), e022612. https://doi.org/10.1136/bmjopen-2018-022612
Eguchi, Hisashi, et al. "Psychosocial factors at work and inflammatory markers: protocol for a systematic review and meta-analysis." BMJ open vol. 8,8 (2018): e022612. doi: https://doi.org/10.1136/bmjopen-2018-022612
Eguchi H, Watanabe K, Kawakami N, Ando E, Arima H, Asai Y, Inoue A, Inoue R, Iwanaga M, Imamura K, Kobayashi Y, Nishida N, Otsuka Y, Sakuraya A, Tsuno K, Shimazu A, Tsutsumi A. Psychosocial factors at work and inflammatory markers: protocol for a systematic review and meta-analysis. BMJ Open. 2018 Aug 29;8(8):e022612. doi: 10.1136/bmjopen-2018-022612. PMID: 30158233; PMCID: PMC6119426.
Copy Download .nbib Format: NLM
Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes.

International journal of cancer

Fowler ME, Akinyemiju TF.
PMID: 28795402
Int J Cancer. 2017 Dec 01;141(11):2215-2227. doi: 10.1002/ijc.30922. Epub 2017 Aug 26.

Proinflammatory dietary patterns have been associated with increased cancer risk and mortality. We present a systematic review and meta-analysis of the current published literature on a dietary inflammatory index (DII) score and its association with cancer risk and mortality...

Cite
Fowler ME, Akinyemiju TF. Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes. Int J Cancer. 2017;141(11):2215-2227doi: 10.1002/ijc.30922.
Fowler, M. E., & Akinyemiju, T. F. (2017). Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes. International journal of cancer, 141(11), 2215-2227. https://doi.org/10.1002/ijc.30922
Fowler, Mackenzie E, and Akinyemiju, Tomi F. "Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes." International journal of cancer vol. 141,11 (2017): 2215-2227. doi: https://doi.org/10.1002/ijc.30922
Fowler ME, Akinyemiju TF. Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes. Int J Cancer. 2017 Dec 01;141(11):2215-2227. doi: 10.1002/ijc.30922. Epub 2017 Aug 26. PMID: 28795402; PMCID: PMC6056732.
Copy Download .nbib Format: NLM
Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation?.

Primary care respiratory journal : journal of the General Practice Airways Group

Yawn BP, Kaplan A.
PMID: 18338090
Prim Care Respir J. 2008 Dec;17(4):199-205. doi: 10.3132/pcrj.2008.00021.

There has been increased awareness and recognition of COPD in both developed and developing nations. As people with COPD are identified and treated before they reach end-stage lung disease, the multiple morbidities associated with COPD have been recognised. These...

Cite
Yawn BP, Kaplan A. Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation?. Prim Care Respir J. 2008;17(4):199-205doi: 10.3132/pcrj.2008.00021.
Yawn, B. P., & Kaplan, A. (2008). Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation?. Primary care respiratory journal : journal of the General Practice Airways Group, 17(4), 199-205. https://doi.org/10.3132/pcrj.2008.00021
Yawn, Barbara P, and Kaplan, Alan. "Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation?." Primary care respiratory journal : journal of the General Practice Airways Group vol. 17,4 (2008): 199-205. doi: https://doi.org/10.3132/pcrj.2008.00021
Yawn BP, Kaplan A. Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation?. Prim Care Respir J. 2008 Dec;17(4):199-205. doi: 10.3132/pcrj.2008.00021. PMID: 18338090; PMCID: PMC6619900.
Copy Download .nbib Format: NLM
[Report from the 18th Tokai Chapter Educational Seminar: Inflammatory Disease].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

Ishizuka T, Fukuzawa Y, Tanigawa T, Shichi D, Morita H, Hiramatsu N.
PMID: 25026792
Nihon Naika Gakkai Zasshi. 2014 May 10;103(5):1195-202. doi: 10.2169/naika.103.1195.

No abstract available.

Cite
Ishizuka T, Fukuzawa Y, Tanigawa T, et al. [Report from the 18th Tokai Chapter Educational Seminar: Inflammatory Disease]. Nihon Naika Gakkai Zasshi. 2014;103(5):1195-202doi: 10.2169/naika.103.1195.
Ishizuka, T., Fukuzawa, Y., Tanigawa, T., Shichi, D., Morita, H., & Hiramatsu, N. (2014). [Report from the 18th Tokai Chapter Educational Seminar: Inflammatory Disease]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 103(5), 1195-202. https://doi.org/10.2169/naika.103.1195
Ishizuka, Tatsuo, et al. "[Report from the 18th Tokai Chapter Educational Seminar: Inflammatory Disease]." Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine vol. 103,5 (2014): 1195-202. doi: https://doi.org/10.2169/naika.103.1195
Ishizuka T, Fukuzawa Y, Tanigawa T, Shichi D, Morita H, Hiramatsu N. [Report from the 18th Tokai Chapter Educational Seminar: Inflammatory Disease]. Nihon Naika Gakkai Zasshi. 2014 May 10;103(5):1195-202. doi: 10.2169/naika.103.1195. Japanese. PMID: 25026792.
Copy Download .nbib Format: NLM
Role of Adiposity-Driven Inflammation in Depressive Morbidity.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Capuron L, Lasselin J, Castanon N.
PMID: 27402495
Neuropsychopharmacology. 2017 Jan;42(1):115-128. doi: 10.1038/npp.2016.123. Epub 2016 Jul 11.

Depression and metabolic disorders, including overweight and obesity, appear tightly interrelated. The prevalence of these conditions is concurrently growing worldwide, and both depression and overweight/obesity represent substantial risk factors for multiple medical complications. Moreover, there is now multiple evidence...

Cite
Capuron L, Lasselin J, Castanon N. Role of Adiposity-Driven Inflammation in Depressive Morbidity. Neuropsychopharmacology. 2016;42(1):115-128doi: 10.1038/npp.2016.123.
Capuron, L., Lasselin, J., & Castanon, N. (2017). Role of Adiposity-Driven Inflammation in Depressive Morbidity. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 42(1), 115-128. https://doi.org/10.1038/npp.2016.123
Capuron, Lucile, et al. "Role of Adiposity-Driven Inflammation in Depressive Morbidity." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 42,1 (2017): 115-128. doi: https://doi.org/10.1038/npp.2016.123
Capuron L, Lasselin J, Castanon N. Role of Adiposity-Driven Inflammation in Depressive Morbidity. Neuropsychopharmacology. 2017 Jan;42(1):115-128. doi: 10.1038/npp.2016.123. Epub 2016 Jul 11. PMID: 27402495; PMCID: PMC5143483.
Copy Download .nbib Format: NLM
[Chronic infection and diseases of internal medicine. Introduction].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

Fujita T.
PMID: 22670299
Nihon Naika Gakkai Zasshi. 2008 Mar 10;97(3):501-2. doi: 10.2169/naika.97.501.

No abstract available.

Cite
Fujita T. [Chronic infection and diseases of internal medicine. Introduction]. Nihon Naika Gakkai Zasshi. 2008;97(3):501-2doi: 10.2169/naika.97.501.
Fujita, T. (2008). [Chronic infection and diseases of internal medicine. Introduction]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 97(3), 501-2. https://doi.org/10.2169/naika.97.501
Fujita, Toshiro. "[Chronic infection and diseases of internal medicine. Introduction]." Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine vol. 97,3 (2008): 501-2. doi: https://doi.org/10.2169/naika.97.501
Fujita T. [Chronic infection and diseases of internal medicine. Introduction]. Nihon Naika Gakkai Zasshi. 2008 Mar 10;97(3):501-2. doi: 10.2169/naika.97.501. Japanese. PMID: 22670299.
Copy Download .nbib Format: NLM
[COPD and systemic inflammation. A link for comorbidity].

Archivos de bronconeumologia

Agustí A.
PMID: 20116744
Arch Bronconeumol. 2009;45:14-7. doi: 10.1016/S0300-2896(09)72858-3.

Patients with chronic obstructive pulmonary disease (COPD) frequently have other chronic diseases (comorbidity) that worsen their clinical status and prognosis. Systemic inflammation may be an important pathogenic factor. The present article critically reviews some of the less well known...

Cite
Agustí A. EPOC e inflamación sistémica. Una vía de enlace para la comorbilidad. [COPD and systemic inflammation. A link for comorbidity]. Arch Bronconeumol. 2009;45:14-7doi: 10.1016/S0300-2896(09)72858-3.
Agustí, A. (2009). EPOC e inflamación sistémica. Una vía de enlace para la comorbilidad. [COPD and systemic inflammation. A link for comorbidity]. Archivos de bronconeumologia, 4514-7. https://doi.org/10.1016/S0300-2896(09)72858-3
Agustí, Alvar. "EPOC e inflamación sistémica. Una vía de enlace para la comorbilidad." [COPD and systemic inflammation. A link for comorbidity]. Archivos de bronconeumologia vol. 45 (2009): 14-7. doi: https://doi.org/10.1016/S0300-2896(09)72858-3
Agustí A. EPOC e inflamación sistémica. Una vía de enlace para la comorbilidad. [COPD and systemic inflammation. A link for comorbidity]. Arch Bronconeumol. 2009;45:14-7. doi: 10.1016/S0300-2896(09)72858-3. Spanish. PMID: 20116744.
Copy Download .nbib Format: NLM
Inflammation--a defense mechanism only?.

Refu'at ha-peh veha-shinayim (1993)

Peretz B.
PMID: 19263866
Refuat Hapeh Vehashinayim (1993). 2008 Nov;25(4):84.

No abstract available.

Cite
Peretz B. Inflammation--a defense mechanism only?. Refuat Hapeh Vehashinayim (1993). 2008;25(4):84
Peretz, B. (2008). Inflammation--a defense mechanism only?. Refu'at ha-peh veha-shinayim (1993), 25(4), 84.
Peretz, Benny. "Inflammation--a defense mechanism only?." Refu'at ha-peh veha-shinayim (1993) vol. 25,4 (2008): 84.
Peretz B. Inflammation--a defense mechanism only?. Refuat Hapeh Vehashinayim (1993). 2008 Nov;25(4):84. PMID: 19263866.
Copy Download .nbib Format: NLM
The "common soil" theory: coronary disease, diabetes and inflammation.

Sao Paulo medical journal = Revista paulista de medicina

Lotufo PA.
PMID: 16358093
Sao Paulo Med J. 2005 Sep 01;123(5):207-8. doi: 10.1590/s1516-31802005000500001. Epub 2005 Dec 08.

No abstract available.

Cite
Lotufo PA. The "common soil" theory: coronary disease, diabetes and inflammation. Sao Paulo Med J. 2005;123(5):207-8doi: 10.1590/s1516-31802005000500001.
Lotufo, P. A. (2005). The "common soil" theory: coronary disease, diabetes and inflammation. Sao Paulo medical journal = Revista paulista de medicina, 123(5), 207-8. https://doi.org/10.1590/s1516-31802005000500001
Lotufo, Paulo Andrade. "The "common soil" theory: coronary disease, diabetes and inflammation." Sao Paulo medical journal = Revista paulista de medicina vol. 123,5 (2005): 207-8. doi: https://doi.org/10.1590/s1516-31802005000500001
Lotufo PA. The "common soil" theory: coronary disease, diabetes and inflammation. Sao Paulo Med J. 2005 Sep 01;123(5):207-8. doi: 10.1590/s1516-31802005000500001. Epub 2005 Dec 08. PMID: 16358093.
Copy Download .nbib Format: NLM
Accelerated aging in perinatally HIV-infected children: clinical manifestations and pathogenetic mechanisms.

Aging

Chiappini E, Bianconi M, Dalzini A, Petrara MR, Galli L, Giaquinto C, De Rossi A.
PMID: 30418933
Aging (Albany NY). 2018 Nov 11;10(11):3610-3625. doi: 10.18632/aging.101622.

BACKGROUND: Premature aging and related diseases have been documented in HIV-infected adults. Data are now emerging also regarding accelerated aging process in HIV-infected children.METHODS: A narrative review was performed searching studies on PubMed published in English language in 2004-2017,...

Cite
Chiappini E, Bianconi M, Dalzini A, et al. Accelerated aging in perinatally HIV-infected children: clinical manifestations and pathogenetic mechanisms. Aging (Albany NY). 2018;10(11):3610-3625doi: 10.18632/aging.101622.
Chiappini, E., Bianconi, M., Dalzini, A., Petrara, M. R., Galli, L., Giaquinto, C., & De Rossi, A. (2018). Accelerated aging in perinatally HIV-infected children: clinical manifestations and pathogenetic mechanisms. Aging, 10(11), 3610-3625. https://doi.org/10.18632/aging.101622
Chiappini, Elena, et al. "Accelerated aging in perinatally HIV-infected children: clinical manifestations and pathogenetic mechanisms." Aging vol. 10,11 (2018): 3610-3625. doi: https://doi.org/10.18632/aging.101622
Chiappini E, Bianconi M, Dalzini A, Petrara MR, Galli L, Giaquinto C, De Rossi A. Accelerated aging in perinatally HIV-infected children: clinical manifestations and pathogenetic mechanisms. Aging (Albany NY). 2018 Nov 11;10(11):3610-3625. doi: 10.18632/aging.101622. PMID: 30418933; PMCID: PMC6286860.
Copy Download .nbib Format: NLM
Facing the urgency of therapies for progressive MS - a Progressive MS Alliance proposal.

Nature reviews. Neurology

Dangond F, Donnelly A, Hohlfeld R, Lubetzki C, Kohlhaas S, Leocani L, Ciccarelli O, Stankoff B, Sormani MP, Chataway J, Bozzoli F, Cucca F, Melton L, Coetzee T, Salvetti M.
PMID: 33483719
Nat Rev Neurol. 2021 Mar;17(3):185-192. doi: 10.1038/s41582-020-00446-9. Epub 2021 Jan 22.

Therapies for infiltrative inflammation in multiple sclerosis (MS) have advanced greatly, but neurodegeneration and compartmentalized inflammation remain virtually untargeted as in other diseases of the nervous system. Consequently, many therapies are available for the relapsing-remitting form of MS, but...

Cite
Dangond F, Donnelly A, Hohlfeld R, et al. Facing the urgency of therapies for progressive MS - a Progressive MS Alliance proposal. Nat Rev Neurol. 2021;17(3):185-192doi: 10.1038/s41582-020-00446-9.
Dangond, F., Donnelly, A., Hohlfeld, R., Lubetzki, C., Kohlhaas, S., Leocani, L., Ciccarelli, O., Stankoff, B., Sormani, M. P., Chataway, J., Bozzoli, F., Cucca, F., Melton, L., Coetzee, T., & Salvetti, M. (2021). Facing the urgency of therapies for progressive MS - a Progressive MS Alliance proposal. Nature reviews. Neurology, 17(3), 185-192. https://doi.org/10.1038/s41582-020-00446-9
Dangond, Fernando, et al. "Facing the urgency of therapies for progressive MS - a Progressive MS Alliance proposal." Nature reviews. Neurology vol. 17,3 (2021): 185-192. doi: https://doi.org/10.1038/s41582-020-00446-9
Dangond F, Donnelly A, Hohlfeld R, Lubetzki C, Kohlhaas S, Leocani L, Ciccarelli O, Stankoff B, Sormani MP, Chataway J, Bozzoli F, Cucca F, Melton L, Coetzee T, Salvetti M. Facing the urgency of therapies for progressive MS - a Progressive MS Alliance proposal. Nat Rev Neurol. 2021 Mar;17(3):185-192. doi: 10.1038/s41582-020-00446-9. Epub 2021 Jan 22. PMID: 33483719.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries